RecruitingPhase 3NCT05651347

Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction

Studying Multifocal lymphangioendotheliomatosis-thrombocytopenia syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Monash University
Principal Investigator
Kirsten Palmer, PhD
Monash University & Monash Health
Intervention
Placebo(other)
Enrollment
336 target
Eligibility
18 years · FEMALE
Timeline
20192027

Study locations (12)

Collaborators

National Health and Medical Research Council, Australia · Cerebral Palsy Alliance · Equity Trustees

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05651347 on ClinicalTrials.gov

Other trials for Multifocal lymphangioendotheliomatosis-thrombocytopenia syndrome

Additional recruiting or active studies for the same condition.

See all trials for Multifocal lymphangioendotheliomatosis-thrombocytopenia syndrome

← Back to all trials